Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
streptokinase
- Development stage
- Phase 4
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intravenous, Intracoronary, Intracatheter
01
Overview
Streptokinase is a purified fibrinolytic bacterial protein derived from group C beta-hemolytic streptococci. It is used as a thrombolytic agent to dissolve blood clots in the treatment of acute myocardial infarction (heart attack), pulmonary embolism, deep venous thrombosis, and arterial thromboembolism. Streptokinase acts by forming a complex with plasminogen, which then converts additional plasminogen molecules into plasmin. Plasmin is an active proteolytic enzyme that degrades fibrin clots as well as fibrinogen and other plasma proteins, leading to the dissolution of blood clots[1][2][3][4][5][6]. The drug is administered intravenously or intracoronarily and has been shown to improve survival when given soon after heart attack symptoms begin[1].
- Brand names
- Streptase
- Other names
- SK
02
Targets
PLG (Plasminogen)
Beyond the preview
Go deeper on streptokinase.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on streptokinase.